Intrinsic Value of S&P & Nasdaq Contact Us

Thorne HealthTech, Inc. THRN NASDAQ

NASDAQ Global Select • Consumer Defensive • Packaged Foods • US • USD

SharesGrow Score
60/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.75
-43.6%

Thorne HealthTech, Inc. (THRN) is a publicly traded company in the Consumer Defensive sector, operating within the Packaged Foods industry. The company is headquartered in New York City, NY, United States. The current CEO is Paul F. Jacobson.

THRN has IPO date of 2021-09-23, 544 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $550.63M.

About Thorne HealthTech, Inc.

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

📍 152 West 57th Street, New York City, NY 10019 📞 929 251 6321
Company Details
SectorConsumer Defensive
IndustryPackaged Foods
CountryUnited States
ExchangeNASDAQ Global Select
CurrencyUSD
IPO Date2021-09-23
CEOPaul F. Jacobson
Employees544
Trading Info
Current Price$10.19
Market Cap$550.63M
52-Week Range3.41-10.2
Beta0.82
ETFNo
ADRNo
CUSIP885260109
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message